Raman Singh

Asia, Singapore

Description

Raman Singh is CEO at Juniper Biologics. He attended Thunderbird School of Global Management.

Investor Profile

Raman Singh has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Series A (100%)

Country Focus

Singapore (100%)

Industry Focus

Biotechnology
Life Science

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Raman Singh frequently co-invest with?

Eisai

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

Openspace

Asia, Central Region, Singapore, Singapore

Co-Investments: 1

EDBI

Asia, Central Region, Singapore, Singapore

Co-Investments: 1

Which angels does Raman Singh often collaborate with?

Wendou Niu

Asia, Singapore

Shared Deals: 1

Kuldeep Singh Rajput

North America, Massachusetts, United States, Boston

Shared Deals: 1

What are some of recent deals done by Raman Singh?

Neuroglee Therapeutics

Singapore, Central Region, Singapore

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

BiotechnologyLife Science

Series ASep 9, 2021

Amount Raised: $10,000,000

Raman Singh

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Raman Singh frequently co-invest with?

Which angels does Raman Singh often collaborate with?

What are some of recent deals done by Raman Singh?

Ready to Raise Capital?

Pages

Free tools